BRYNOVIN Trademark

Trademark Overview

On Tuesday, May 23, 2023, a trademark application was filed for BRYNOVIN with the United States Patent and Trademark Office. The USPTO has given the BRYNOVIN trademark a serial number of 98008966. The federal status of this trademark filing is REGISTERED as of Tuesday, September 16, 2025. This trademark is owned by Azurity Pharmaceuticals, Inc.. The BRYNOVIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diabetes
brynovin

General Information

Serial Number98008966
Word MarkBRYNOVIN
Filing DateTuesday, May 23, 2023
Status700 - REGISTERED
Status DateTuesday, September 16, 2025
Registration Number7950846
Registration DateTuesday, September 16, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 24, 2023
Primary Code005
First Use Anywhere DateMonday, June 30, 2025
First Use In Commerce DateMonday, June 30, 2025

Trademark Owner History

Party NameAzurity Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801
Party NameAzurity Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801
Party NameAzurity Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Trademark Events

Event DateEvent Description
Friday, May 26, 2023NEW APPLICATION ENTERED
Saturday, June 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 15, 2024ASSIGNED TO EXAMINER
Thursday, February 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2024SOU EXTENSION 1 FILED
Tuesday, May 28, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 7, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 27, 2024SOU EXTENSION 1 GRANTED
Thursday, June 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 18, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, March 18, 2025SOU EXTENSION 2 FILED
Tuesday, March 18, 2025SOU EXTENSION 2 GRANTED
Thursday, July 31, 2025USE AMENDMENT FILED
Thursday, July 31, 2025TEAS STATEMENT OF USE RECEIVED
Saturday, August 2, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 26, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 26, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 16, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, September 16, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

brynovin diabetes treatment preparations pharmaceutical